Cancer Research Institute Names 26 New Postdoctoral Fellows
December 17, 2025
New York, NY – The Cancer Research Institute (CRI) is pleased to announce the Winter 2025 Class of CRI Irvington and Immuno-Informatics Postdoctoral Fellows, making investments in 26 promising postdoctoral fellowship trainees whose research spans tumor immunology, cancer prevention, data science, and cellular engineering.
This cohort represents a growing need, as fellowship applications dramatically increased this year in the face of funding uncertainty. CRI responded with an ongoing commitment to filling these gaps, funding 50 percent more fellows this year than originally anticipated.
“Postdocs are the invisible engine of biomedical discovery,” said Miriam Merad, MD, PhD, of CRI’s Scientific Advisory Council. “At a time when federal support is faltering, CRI is once again stepping up – just as it did decades ago when cancer immunology had few champions. Supporting these young scientists is not just an act of resilience; it’s a commitment to the future of science and the patients who depend on it.”
Each CRI Fellowship provides $243,000 over three years and supports high-impact research at leading academic institutions.
“A future immune to cancer begins with bold ideas—and the brilliant scientists who pursue them,” said Alicia Zhou, PhD, CEO of CRI. “At CRI, we are proud to support the next generation of leaders in cancer immunotherapy through our steadfast investment in early-career research and training.”
From a single bold idea in 1971 to a global network of more than 1,600 fellows, CRI’s support for early-career scientists has helped turn immunotherapy from a fringe concept into a front-line cancer treatment. Today’s fellows are not just continuing that legacy—they’re redefining what’s possible
https://www.cancerresearch.org/media-roo...-post-docs
December 17, 2025
New York, NY – The Cancer Research Institute (CRI) is pleased to announce the Winter 2025 Class of CRI Irvington and Immuno-Informatics Postdoctoral Fellows, making investments in 26 promising postdoctoral fellowship trainees whose research spans tumor immunology, cancer prevention, data science, and cellular engineering.
This cohort represents a growing need, as fellowship applications dramatically increased this year in the face of funding uncertainty. CRI responded with an ongoing commitment to filling these gaps, funding 50 percent more fellows this year than originally anticipated.
“Postdocs are the invisible engine of biomedical discovery,” said Miriam Merad, MD, PhD, of CRI’s Scientific Advisory Council. “At a time when federal support is faltering, CRI is once again stepping up – just as it did decades ago when cancer immunology had few champions. Supporting these young scientists is not just an act of resilience; it’s a commitment to the future of science and the patients who depend on it.”
Each CRI Fellowship provides $243,000 over three years and supports high-impact research at leading academic institutions.
“A future immune to cancer begins with bold ideas—and the brilliant scientists who pursue them,” said Alicia Zhou, PhD, CEO of CRI. “At CRI, we are proud to support the next generation of leaders in cancer immunotherapy through our steadfast investment in early-career research and training.”
From a single bold idea in 1971 to a global network of more than 1,600 fellows, CRI’s support for early-career scientists has helped turn immunotherapy from a fringe concept into a front-line cancer treatment. Today’s fellows are not just continuing that legacy—they’re redefining what’s possible
https://www.cancerresearch.org/media-roo...-post-docs